I. Judson
Impact in
-
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
-
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
Papers in
-
- Cancer, Hypoxia, and Metabolism 5
- Cancer Genomics and Diagnostics 5
- Oncology 14
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 5
- Metal complexes synthesis and properties 3
- Co-authors
- Hilary CalvertW J van der VijghS. AshleyJanine MansiD C TalbotIan E. SmithA H CalvertMartin O. Leach
- Journals
- Journal of Clinical Oncology (7 papers)European Journal of Cancer (4 papers)British Journal of Cancer (3 papers)Lung Cancer (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- United KingdomAustraliaNetherlands
In The Last Decade
I. Judson
29 papers receiving 297 citations
Peers
Comparison fields: 5 of 59
- Oncology 153
- Cancer Research 52
- Toxicology 9
- Pathology and Forensic Medicine 47
- Hematology 22
Countries citing papers authored by I. Judson
This map shows the geographic impact of I. Judson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Judson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Judson more than expected).
Fields of papers citing papers by I. Judson
This network shows the impact of papers produced by I. Judson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Judson. The network helps show where I. Judson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I. Judson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 16 | |
| 2 | Pharmacodynamic effects in patients treated with 6 hour infusion of the demethylating agent 5-aza-2 ' deoxycytidine (decitabine) | 2005 | 1 |
| 3 | 2004 | 11 | |
| 4 | 2004 | 1 | |
| 5 | 2004 | 6 | |
| 6 | The contemporary drug development process: advances and challenges in preclinical and clinical development. | 2003 | 16 |
| 7 | 1999 | 10 | |
| 8 | 1999 | 8 | |
| 9 | Evidence for the duration of the antifolate action of the thymidylate synthase (TS) inhibitor ZD9331 using plasma dUrd as a surrogate marker of enzyme inhibition | 1998 | 1 |
| 10 | Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks | 1998 | 2 |
| 11 | Plasma 2 '-deoxyuridine (dUrd) as a surrogate marker of thymidylate synthase (TS) inhibition in patients in phase I clinical trials of the TS inhibitor ZD9331 | 1998 | 1 |
| 12 | Preparation and evaluation of N-acylated anthracycline analogues for radiolabelling with I-124 and Br-76 - potential radiotracers for in vivo assessment of multidrug resistance | 1998 | 1 |
| 13 | The activity of N-(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenografts. | 1996 | 3 |
| 14 | 1994 | 0 | |
| 15 | Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity. | 1993 | 68 |
| 16 | 1991 | 55 | |
| 17 | 1991 | 31 | |
| 18 | 1989 | 1 | |
| 19 | PRECLINICAL AND CLINICAL-STUDIES WITH N-2, N-4, N-6-TRIHYDROXYMETHYL, N-2, N-4, N-6-TRIMETHYLMELAMINE, AN ALTERNATIVE TO PENTAMETHYLMELAMINE | 1985 | 1 |
| 20 | REPORT ON THE PHASE I TRIAL OF N-2, N-4, N-6-TRIHYDROXYMETHYL-N-2, N-4, N-6-TRIMETHYLMELAMINE (TRIMELAMOL) | 1985 | 1 |
About I. Judson
I. Judson is a scholar working on Cancer Research, Oncology, Philosophy, Genetics and Gastroenterology, having authored 31 papers that have together received 307 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Cancer, Hypoxia, and Metabolism (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Genomics and Diagnostics (5 papers), Health, Medicine and Society (3 papers), Metal complexes synthesis and properties (3 papers), Hermeneutics and Narrative Identity (3 papers) and Aging, Elder Care, and Social Issues (3 papers). The work is most often cited by research in Oncology (153 citations), Cancer Research (52 citations), Toxicology (9 citations), Pathology and Forensic Medicine (47 citations) and Hematology (22 citations). I. Judson has collaborated with scholars based in United Kingdom, Australia and Netherlands. Frequent co-authors include Hilary Calvert, W J van der Vijgh, S. Ashley, Janine Mansi, D C Talbot, Ian E. Smith, A H Calvert, Martin O. Leach, Paul M.J. McSheehy and TJ Powles. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer, Lung Cancer and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.